1
Thombs, BD, Bass, EB, Ford, DE, Stewart, KJ, Tsilidis, KK, Patel, U, et al Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med
2006; 21: 30–8.
2
Beekman, AT, Copeland, JR, Prince, MJ. Review of community prevalence of depression in later life. Br J Psychiatry
1999; 174: 307–11.
3
Barth, J, Schumacher, M, Herrmann-Lingen, C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med
2004; 66: 802–13.
4
Nicholson, A, Kuper, H, Hemingway, H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J
2006; 27: 2763–74.
5
Meijer, A, Conradi, HJ, Bos, EH, Thombs, BD, van Melle, JP, de Jonge, P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry
2011; 33: 203–16.
6
Frasure-Smith, N, Lesperance, F. Depression and cardiac risk: present status and future directions. Heart
2010; 96: 173–6.
7
Van Melle, JP, de Jonge, P, Ormel, J, Crijns, HJ, van Veldhuisen, DJ, Honig, A, et al Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J
2005; 26: 2650–6.
8
Delisle, VC, Beck, AT, Ziegelstein, C, Thombs, BD. Symptoms of heart disease or its treatment may increase Beck Depression Inventory Scores in hospitalized post-myocardial infarction patients. J Psychosom Res
2012; 73: 157–62.
9
Freedland, KE, Rich, MW, Skala, JA, Carney, RM, Davila-Roman, VG, Jaffe, AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med
2003; 65: 119–28.
10
Raison, CL, Capuron, L, Miller, AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol
2006; 27: 24–31.
11
Evans, DL, Charney, DS, Lewis, L, Golden, RN, Gorman, JM, Krishnan, KR, et al Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry
2005; 58: 175–89.
12
Carney, RM, Freedland, KE, Miller, GE, Jaffe, AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res
2002; 53: 897–902.
13
Golden, SH, Lazo, M, Carnethon, M, Bertoni, AG, Schreiner, PJ, Diez Roux, AV, et al Examining a bidirectional association between depressive symptoms and diabetes. JAMA
2008; 299: 2751–9.
14
Anda, RF, Williamson, DF, Escobedo, LG, Mast, EE, Giovino, GA, Remington, PL. Depression and the dynamics of smoking. A national perspective. JAMA
1990; 264: 1541–5.
15
Carney, RM, Blumenthal, JA, Catellier, D, Freedland, KE, Berkman, LF, Watkins, LL, et al Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol
2003; 92: 1277–81.
16
Frasure-Smith, N, Lesperance, F, Juneau, M, Talajic, M, Bourassa, MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med
1999; 61: 26–37.
17
Parashar, S, Rumsfeld, JS, Spertus, JA, Reid, KJ, Wenger, NK, Krumholz, HM, et al Time course of depression and outcome of myocardial infarction. Arch Intern Med
2006; 166: 2035–43.
18
Lee, KL, Woodlief, LH, Topol, EJ, Weaver, WD, Betriu, A, Col, J, et al Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation
1995; 91: 1659–68.
19
Mueller, HS, Cohen, LS, Braunwald, E, Forman, S, Feit, F, Ross, A, et al Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation
1992; 85: 1254–64.
20
Denollet, J, Martens, EJ, Smith, OR, Burg, MM. Efficient assessment of depressive symptoms and their prognostic value in myocardial infarction patients. J Affect Disord
2010; 120: 105–11.
21
Cooper, H, Patall, EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychol Methods
2009; 14: 165–76.
22
Simmonds, MC, Higgins, JP, Stewart, LA, Tierney, JF, Clarke, MJ, Thompson, SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials
2005; 2: 209–17.
23
Curran, PJ, Hussong, AM. Integrative data analysis: the simultaneous analysis of multiple data sets. Psychol Methods
2009; 14: 81–100.
24
Poppe, KK, Doughty, RN, Yu, CM, Quintana, M, Moller, JE, Klein, AL, et al Understanding differences in results from literature-based and individual patient meta-analyses: an example from meta-analyses of observational data. Int J Cardiol
2011; 148: 209–13.
25
Van Walraven, C. Individual patient meta-analysis – rewards and challenges. J Clin Epidemiol
2010; 63: 235–7.
26
Stewart, LA, Tierney, JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof
2002; 25: 76–97.
27
Van Melle, JP, De Jonge, P, Spijkerman, TA, Tijssen, JG, Ormel, J, Van Veldhuisen, DJ, et al Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med
2004; 66: 814–22.
28
Khot, UN, Jia, G, Moliterno, DJ, Lincoff, AM, Khot, MB, Harrington, RA, et al Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA
2003; 290: 2174–81.
29
Burns, RJ, Gibbons, RJ, Yi, Q, Roberts, RS, Miller, TD, Schaer, GL, et al The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol
2002; 39: 30–6.
30
Volpi, A, De Vita, C, Franzosi, MG, Geraci, E, Maggioni, AP, Mauri, F, et al Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation
1993; 88: 416–29.
31
Thombs, BD, Ziegelstein, RC, Parakh, K, Stewart, DE, Abbey, SE, Grace, SL. Probit structural equation regression model: general depressive symptoms predicted post-myocardial infarction mortality after controlling for somatic symptoms of depression. J Clin Epidemiol
2008; 61: 832–9.
32
Golden, SH, Lazo, M, Carnethon, M, Bertoni, AG, Schreiner, PJ, Diez Roux, AV, et al Examining a bidirectional association between depressive symptoms and diabetes. JAMA
2008; 299: 2751–9.
33
Rafanelli, C, Milaneschi, Y, Roncuzzi, R, Pancaldi, LG. Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up. Psychosomatics
2010; 51: 8–13.
34
Smith, CT, Williamson, PR, Marson, AG. Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes. Stat Med
2005; 24: 1307–19.
35
Smith, CT, Williamson, PR, Marson, AG. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. J Eval Clin Pract
2005; 11: 468–78.
36
Sauerbrei, W, Schumacher, M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med
1992; 11: 2093–109.
37
Whooley, MA, de Jonge, P, Vittinghoff, E, Otte, C, Moos, R, Carney, RM, et al Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA
2008; 300: 2379–88.
38
Clarke, MJ, Stewart, LA. Meta-analyses using individual patient data. J Eval Clin Pract
1997; 3: 207–12.
39
Hosseini, SH, Yousefnejad, K, Tabiban, S, Nesarhoseyni, V, Bagheri, B, Kiasari, AM, et al Effects of depression and anxiety symptoms on cardiac mortality following myocardial infarction: a 2-year follow-up. Int J Psych Clin Pract
2011; 15: 91–6.
40
Van den Brink, RH, van Melle, JP, Honig, A, Schene, AH, Crijns, HJ, Lambert, FP, et al Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J
2002; 144: 219–25.
41
Carney, RM, Freedland, KE, Steinmeyer, B, Blumenthal, JA, de Jonge, P, Davidson, KW, et al History of depression and survival after acute myocardial infarction. Psychosom Med
2009; 71: 253–9.
42
Carney, RM, Blumenthal, JA, Stein, PK, Watkins, L, Catellier, D, Berkman, LF, et al Depression, heart rate variability, and acute myocardial infarction. Circulation
2001; 104: 2024–8.
43
Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators. Am Heart J
2000; 139: 1–9.
44
De Jonge, P, van den Brink, RH, Spijkerman, TA, Ormel, J. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol
2006; 48: 2204–8.
45
Drago, S, Bergerone, S, Anselmino, M, Varalda, PG, Cascio, B, Palumbo, L, et al Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol
2007; 115: 46–51.
46
Lane, D, Carroll, D, Ring, C, Beevers, DG, Lip, GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med
2001; 63: 221–30.
47
Lane, D, Carroll, D, Ring, C, Beevers, DG, Lip, GY. Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?
QJM
2000; 93: 739–44.
48
Lauzon, C, Beck, CA, Huynh, T, Dion, D, Racine, N, Carignan, S, et al Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ
2003; 168: 547–52.
49
Parakh, K, Thombs, BD, Fauerbach, JA, Bush, DE, Ziegelstein, RC. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol
2008; 101: 602–6.
50
Shiotani, I, Sato, H, Kinjo, K, Nakatani, D, Mizuno, H, Ohnishi, Y, et al Depressive symptoms predict 12-month prognosis in elderly patients with acute myocardial infarction. J Cardiovasc Risk
2002; 9: 153–60.
51
Steeds, RP, Bickerton, D, Smith, MJ, Muthusamy, R. Assessment of depression following acute myocardial infarction using the Beck depression inventory. Heart
2004; 90: 217–8.
52
Grace, SL, Abbey, SE, Pinto, R, Shnek, ZM, Irvine, J, Stewart, DE. Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation. Psychosom Med
2005; 67: 52–8.
53
Welin, C, Lappas, G, Wilhelmsen, L. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med
2000; 247: 629–39.
54
Doyle, F, McGee, HM, De La Harpe, D, Shelley, E, Conroy, R. The Hospital Anxiety and Depression Scale depression subscale, but not the Beck Depression Inventory – Fast Scale, identifies patients with acute coronary syndrome at elevated risk of 1-year mortality. J Psychosom Res
2006; 60: 461–7.
55
Doyle, F, Conroy, R, McGee, H, Delaney, M. Depressive symptoms in persons with acute coronary syndrome: specific symptom scales and prognosis. J Psychosom Res
2010; 68: 121–30.
56
Carney, RM, Freedland, KE, Rich, MW, Jaffe, AS. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med
1995; 17: 142–9.
57
Musselman, DL, Evans, DL, Nemeroff, CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry
1998; 55: 580–92.
58
Howren, MB, Lamkin, DM, Suls, J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med
2009; 71: 171–86.
59
Musselman, DL, Tomer, A, Manatunga, AK, Knight, BT, Porter, MR, Kasey, S, et al Exaggerated platelet reactivity in major depression. Am J Psychiatry
1996; 153: 1313–7.
60
Laghrissi-Thode, F, Wagner, WR, Pollock, BG, Johnson, PC, Finkel, MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry
1997; 42: 290–5.
61
Rieckmann, N, Kronish, IM, Haas, D, Gerin, W, Chaplin, WF, Burg, MM, et al Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J
2006; 152: 922–7.
62
Carney, RM, Freedland, KE, Eisen, SA, Rich, MW, Jaffe, AS. Major depression and medication adherence in elderly patients with coronary artery disease
Health Psychol
1995; 14: 88–90.
63
May, HT, Sheng, X, Catinella, AP, Horne, BD, Carlquist, JF, Joy, E. Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression. J Psychosom Res
2010; 69: 169–74.
64
Blumenthal, JA, Williams, RS, Wallace, AG, Williams, RB, Needles, TL. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med
1982; 44: 519–27.
65
Myers, V, Gerber, Y, Benyamini, Y, Goldbourt, U, Drory, Y. Post-myocardial infarction depression: increased hospital admissions and reduced adoption of secondary prevention measures – a longitudinal study
J Psychosom Res
2012; 72: 5–10.
66
Kronish, IM, Rieckmann, N, Halm, EA, Shimbo, D, Vorchheimer, D, Haas, DC, et al Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med
2006; 21: 1178–83.
67
Ziegelstein, RC, Fauerbach, JA, Stevens, SS, Romanelli, J, Richter, DP, Bush, DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med
2000; 160: 1818–23.
68
Schweitzer, RD, Head, K, Dwyer, JW. Psychological factors and treatment adherence behavior in patients with chronic heart failure. J Cardiovasc Nurs
2007; 22: 76–83.
69
Joekes, K, Van Elderen, T, Schreurs, K. Self-efficacy and overprotection are related to quality of life, psychological well-being and self-management in cardiac patients. J Health Psychol
2007; 12: 4–16.
70
Sarkar, U, Ali, S, Whooley, MA. Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med
2007; 69: 306–12.
71
Sarkar, U, Ali, S, Whooley, MA. Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study. Health Psychol
2009; 28: 166–73.
72
Page, RL, Lindenfeld, J. The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient. Curr Cardiol Rep
2012; 14: 276–84.
73
Schmid, CH, Landa, M, Jafar, TH, Giatras, I, Karim, T, Reddy, M, et al Constructing a database of individual clinical trials for longitudinal analysis. Control Clin Trials
2003; 24: 324–40.
74
Sternberg, KJ, Baradaran, LP, Abbott, CB, Lamb, ME, Guterman, E. Type of violence, age, and gender differences in the effects of family violence on children's behavior problems: a mega-analysis. Dev Rev
2006; 26: 89–112.
75
Wicherts, JM, Borsboom, D, Kats, J, Molenaar, D. The poor availability of psychological research data for reanalysis. Am Psychol
2006; 61: 726–8.
76
Berkman, LF, Blumenthal, J, Burg, M, Carney, RM, Catellier, D, Cowan, MJ, et al Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA
2003; 289: 3106–16.
77
Zuidersma, M, Conradi, HJ, van Melle, J, Ormel, J, de Jonge, P. Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J. Psychosom Res
2013; 74: 25–30.
78
Van Melle, JP, de Jonge, P, Honig, A, Schene, AH, Kuyper, AMG, Crijns, HJGM, et al Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry
2007; 190: 460–6.
79
Bauer, DJ, Hussong, AM. Psychometric approaches for developing commensurate measures across independent studies: traditional and new models. Psychol Methods
2009; 14: 101–25.
80
Eagle, KA, Lim, MJ, Dabbous, OH, Pieper, KS, Goldberg, RJ, Van de Werf, F, et al A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA
2004; 291: 2727–33.
81
Wakabayashi, K, Gonzalez, MA, Delhaye, C, Ben-Dor, I, Maluenda, G, Collins, SD, et al Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol
2010; 106: 305–9.
82
Kronish, IM, Rieckmann, N, Schwartz, JE, Schwartz, DR, Davidson, KW. Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?
Psychosom Med
2009; 71: 697–703.
83
Meurs, M, Zuidersma, M, Dickens, C, de Jonge, P. Examining the relation between post myocardial infarction depression and cardiovascular prognosis using a validated prediction model for post myocardial mortality. Int J Cardiol
2012; .
84
Ahern, DK, Gorkin, L, Anderson, JL, Tierney, C, Hallstrom, A, Ewart, C, et al Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol
1990; 66: 59–62.
85
Frasure-Smith, N, Lesperance, F, Talajic, M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?
Health Psychol
1995; 14: 388–98.
86
Irvine, J, Basinski, A, Baker, B, Jandciu, S, Paquette, M, Cairns, J, et al Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med
1999; 61: 729–37.
87
Kaufmann, MW, Fitzgibbons, JP, Sussman, EJ, Reed, JF, Einfalt, JM, Rodgers, JK, et al Relation between myocardial infarction, depression, hostility, and death. Am Heart J
1999; 138: 549–54.
88
Ladwig, KH, Kieser, M, Konig, J, Breithardt, G, Borggrefe, M. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J
1991; 12: 959–64.
89
Mayou, RA, Gill, D, Thompson, DR, Day, A, Hicks, N, Volmink, J, et al Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med
2000; 62: 212–9.
90
Nakatani, D, Sato, H, Sakata, Y, Shiotani, I, Kinjo, K, Mizuno, H, et al Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J
2005; 150: 652–8.
91
Rumsfeld, JS, Jones, PG, Whooley, MA, Sullivan, MD, Pitt, B, Weintraub, WS, et al Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J
2005; 150: 961–7.
92
Silverstone, PH. Depression and outcome in acute myocardial infarction. BMJ
1987; 294: 219–20.
93
Smolderen, KG, Spertus, JA, Reid, KJ, Buchanan, DM, Krumholz, HM, Denollet, J, et al The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes
2009; 2: 328–37.
94
Sorensen, C, Brandes, A, Hendricks, O, Thrane, J, Friis-Hasche, E, Haghfelt, T, et al Depression assessed over 1-year survival in patients with myocardial infarction. Acta Psychiatr Scand
2006; 113: 290–7.
95
Strik, JJ, Lousberg, R, Cheriex, EC, Honig, A. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res
2004; 56: 59–66.
96
Sydeman, SJ. Impact of negative emotions on recurrent cardiovascular events following hospitalization for myocardial infarction or unstable angina. , University of South Florida, 1999.
Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis
eLetters
No eLetters have been published for this article.